首页
订购/客服:400-666-5481

Salirasib

    
≥98%

Salirasib

源叶(MedMol)
S83728 一键复制产品信息
162520-00-5
C22H30O2S
358.54
2-[[(2E,6E)-3,7,11-三甲基-2,6,10-十二烷三烯-1-基]硫代]苯甲酸;Farnesyl thiosalicylate; Farnesyl thiosalicylic acid; Lopac-F-8175; Salirasib; FTS; S-Farnesylthiosalicylic acid; 2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,1
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S83728-5mg促销
≥98%

¥100.00 ¥80.00

货期:2-3天 - - - -
S83728-10mg促销
99.50%

¥145.00 ¥116.00

5 - - - -
S83728-25mg促销
99.50%

¥245.00 ¥220.00

1 - - - -
S83728-50mg
99.50%

¥400.00

6 - - - -
S83728-100mg
≥98%

¥640.00

货期:2-3天 - - - -
S83728-200mg
≥98%

¥1200.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Salirasib is a Ras inhibitor that inhibits specifically both oncogenically activated Ras and growth factor receptor-mediated Ras activation, resulting in the inhibition of Ras-dependent tumor growth.
靶点: Ki: 2.6 μM (PPMTase);Autophagy; Ras
体外研究: Salirasib (12.5-100 μM) inhibits the proliferation of ELT3 cells in a dose-dependent manner with an average IC50 of 58.57±4.59 μM. The effects of Salirasib on the TSC2-null cells are evidently mimicked by DN-Rheb but not by DN-Ras. Salirasib reduces Rheb in TSC2-null cells and TSC2 expression rescues the cells from the inhibitory effect of Salirasib. Salirasib reduces phosphorylation of S6K but not of ERK in the TSC2-null ELT3 cells. Salirasib (50, 100, 150 μM) induces a dose- and time-dependent decrease of cell growth in HCC cells. Salirasib reduces cell proliferation through modulation of cell cycle effectors and inhibitors. Salirasib induces apoptosis in HepG2 and Hep3B cells. The growth inhibitory effect of salirasib in HCC cell lines is associated with mTOR inhibition independent of ERK or Akt activation
体内研究: Salirasib (40, 60 or 80 mg/kg, p.o.) significantly inhibits the tumor growth in a dose dependent manner in vivo[1]. Salirasib (5 mg/kg, i.p.) significantly decreases Ras expression in the dy2J/dy2Jmice, and causes an increase in Ras expression which is by far much lower than the increase observed in the dy2J/dy2J mice. Salirasib treatment is associated with significantly inhibition of both MMP-2 and MMP-9 activities in the dy2J/dy2J mice[2]. Salirasib (10 mg/kg, i.p.) inhibits tumour growth in a subcutaneous xenograft mice model without weight loss
参考文献: 1. Makovski V, et al. Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis. Int J Cancer. 2012 Mar 15;130(6):1420-9. 2. Nevo Y, et al. Chapman J. The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy. PLoS One. 2011 Mar 22;6(3):e18049. 3. Charette N, et al. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition. Mol Cancer. 2010 Sep 22;9:256.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.789 ml 13.945 ml 27.891 ml
5 mM 0.558 ml 2.789 ml 5.578 ml
10 mM 0.279 ml 1.395 ml 2.789 ml
50 mM 0.056 ml 0.279 ml 0.558 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×